Alkylation of methyl 4-hydroxybenzoate with a-methoxy-w-methanesulfonylpoly(ethylene glycol) (M = 5 000) and a,wbismethanesulfonylpoly(ethylene glycol) (M = 10 000) has been used to prepare 4-poly(ethylene glycol)oxybenzoic acids. Reactions of chlorides of these acids with 2-amino-2-methylpropanenitrile or 2-amino-2,3-dimethylbutanenitrile were used to prepare the corresponding acylaminonitriles, which were subsequently cyclized and hydrolyzed to give the following acylamino acids: 2-{4-[amethoxypoly(ethylene glycol)]oxybenzoylamino}-2,3-dimethylbutyric acid and 2-(4-{a-[4-(1-carbonyl-1-methylethylcarbamoyl)phenoxy]poly(ethylene glycol)-w-yloxy}benzoylamino)-2-methylpropionic acid.In recent years there have appeared increasing numbers of applications of poly(ethylene glycols) [a-methoxypoly(ethylene glycol): mPEG; poly(ethylene glycol): PEG] functionalized at the end of their chain with carboxylic group. 1 These polymers are used in syntheses of conjugates of poly(ethylene glycol) with medical drugs, as well as carriers in liquid-phase combinatorial synthesis, or in syntheses of block copolymers designed for a variety of applications. 1,2 Literature 2 describes numerous methods of preparation of poly(ethylene glycols) carrying a terminal carboxylic group attached via the aliphatic residue -CH 2 -. These syntheses have the disadvantage of incomplete conversion of the terminal hydroxyl groups into carboxylic functional groups, and oxidative procedures are also connected with significant degradation of the poly(ethylene glycol) chain. 2a,g However, the contemporary synthetic methods necessitate application of such poly(ethylene glycol)carboxylic acids that contain practically no free alcoholic groups. If poly(ethylene glycol)carboxylic acids should be applied as carriers of medical drugs, which are attached to the polymer by means of ester linkage, then another key requirement consists in the possibility of rate control of enzymatic hydrolysis of the ester linkages by blood esterases. 3 The hydrolysis rate and, hence, the rate of release of the drug from the carrier is controlled in these cases by both the molecular weight 3 of the polymeric carrier (PEG) and by varying extent of steric accessibility of the carboxylic functional groups. 3a